We have previously reported that plasma ADAMTS13 activity (ADAMTS13:AC) was reduced in patients with SOS, formerly called hepatic veno-occlusive disease (VOD), after hematopoietic stem cell transplantation (SCT) [12]. This evidence concerns the gene ADAMTS13 and spondylo-ocular syndrome.